These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37052145)

  • 41. Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol.
    Anderson RI; Becker HC
    Alcohol Clin Exp Res; 2017 Aug; 41(8):1402-1418. PubMed ID: 28425121
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism.
    Zorrilla EP; Heilig M; de Wit H; Shaham Y
    Drug Alcohol Depend; 2013 Mar; 128(3):175-86. PubMed ID: 23294766
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involvement of Activated Brain Stress Responsive Systems in Excessive and "Relapse" Alcohol Drinking in Rodent Models: Implications for Therapeutics.
    Zhou Y; Kreek MJ
    J Pharmacol Exp Ther; 2018 Jul; 366(1):9-20. PubMed ID: 29669731
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The corticotropin releasing hormone-1 (CRH1) receptor antagonist pexacerfont in alcohol dependence: a randomized controlled experimental medicine study.
    Kwako LE; Spagnolo PA; Schwandt ML; Thorsell A; George DT; Momenan R; Rio DE; Huestis M; Anizan S; Concheiro M; Sinha R; Heilig M
    Neuropsychopharmacology; 2015 Mar; 40(5):1053-63. PubMed ID: 25409596
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A key role for corticotropin-releasing factor in alcohol dependence.
    Heilig M; Koob GF
    Trends Neurosci; 2007 Aug; 30(8):399-406. PubMed ID: 17629579
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alcohol dependence and free-choice drinking in mice.
    Griffin WC
    Alcohol; 2014 May; 48(3):287-93. PubMed ID: 24530006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contribution of Dynorphin and Orexin Neuropeptide Systems to the Motivational Effects of Alcohol.
    Anderson RI; Moorman DE; Becker HC
    Handb Exp Pharmacol; 2018; 248():473-503. PubMed ID: 29526023
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurokinin receptors in drug and alcohol addiction.
    Schank JR
    Brain Res; 2020 May; 1734():146729. PubMed ID: 32067964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The urocortin 1 neurocircuit: ethanol-sensitivity and potential involvement in alcohol consumption.
    Ryabinin AE; Weitemier AZ
    Brain Res Rev; 2006 Sep; 52(2):368-80. PubMed ID: 16766036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene expression changes in serotonin, GABA-A receptors, neuropeptides and ion channels in the dorsal raphe nucleus of adolescent alcohol-preferring (P) rats following binge-like alcohol drinking.
    McClintick JN; McBride WJ; Bell RL; Ding ZM; Liu Y; Xuei X; Edenberg HJ
    Pharmacol Biochem Behav; 2015 Feb; 129():87-96. PubMed ID: 25542586
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Medicinal plants in the phytotherapy of alcohol or nicotine addiction. Implication for plants in vitro cultures].
    Ozarowski M; Mikołajczak PŁ; Thiem B
    Przegl Lek; 2013; 70(10):869-74. PubMed ID: 24501814
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting brain angiotensin and corticotrophin-releasing hormone systems interaction for the treatment of mood and alcohol use disorders.
    Sommer WH; Saavedra JM
    J Mol Med (Berl); 2008 Jun; 86(6):723-8. PubMed ID: 18449521
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alcohol: mechanisms of addiction and reinforcement.
    Lewis MJ
    Adv Alcohol Subst Abuse; 1990; 9(1-2):47-66. PubMed ID: 2165735
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Corticotropin-releasing factor acting on corticotropin-releasing factor receptor type 1 is critical for binge alcohol drinking in mice.
    Kaur S; Li J; Stenzel-Poore MP; Ryabinin AE
    Alcohol Clin Exp Res; 2012 Feb; 36(2):369-76. PubMed ID: 21895713
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of hypothalamic corticotropin-releasing factor in mediating alcohol-induced activation of the rat hypothalamic-pituitary-adrenal axis.
    Rivier C
    Front Neuroendocrinol; 2014 Apr; 35(2):221-33. PubMed ID: 24211830
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biobehavioral Interactions Between Stress and Alcohol.
    Weera MM; Gilpin NW
    Alcohol Res; 2019 Oct; 40(1):. PubMed ID: 31649835
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The novel, selective, brain-penetrant neuropeptide Y Y2 receptor antagonist, JNJ-31020028, tested in animal models of alcohol consumption, relapse, and anxiety.
    Cippitelli A; Rezvani AH; Robinson JE; Eisenberg L; Levin ED; Bonaventure P; Motley ST; Lovenberg TW; Heilig M; Thorsell A
    Alcohol; 2011 Sep; 45(6):567-76. PubMed ID: 21145691
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of voluntary alcohol drinking on corticotropin-releasing factor and preprodynorphin mRNA levels in the central amygdala of Sardinian alcohol-preferring rats.
    Zhou Y; Colombo G; Gessa GL; Kreek MJ
    Neurosci Lett; 2013 Oct; 554():110-4. PubMed ID: 24021806
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Neurobiology of Alcohol Dependence and Implications on Treatment].
    Eşel E; Dinç K
    Turk Psikiyatri Derg; 2017; 28(1):51-60. PubMed ID: 28291298
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amygdala, neuropeptides, and chronic pain-related affective behaviors.
    Neugebauer V; Mazzitelli M; Cragg B; Ji G; Navratilova E; Porreca F
    Neuropharmacology; 2020 Jun; 170():108052. PubMed ID: 32188569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.